Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Instrumentation Technology
3.2. Snippet by Application
3.3. Snippet by Services and Software
3.4. Snippet by End User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. The Growing Number of Research on Biomarkers Usage for Cancer
4.1.1.2. Rising Technological Adavancements
4.1.2. Restraints
4.1.2.1. The High Cost and Limitations Associated with Proteomic Technology
4.1.3. Opportunity
4.1.3.1. Rising Collaboration by Key Players or Several Organizations
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Instrumentation Technology
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Instrumentation Technology
7.1.2. Market Attractiveness Index, By Instrumentation Technology
7.2. Chromatography *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.2.3. HPLC
7.2.4. Ion Chromatography
7.2.5. Affinity Chromatography
7.2.6. Supercritical Fluid Chromatography
7.3. Protein Microarrays
7.3.1. Biochips
7.3.1.1. Lab-On-Chips (Microfluidics)
7.3.1.2. Protein Chips
7.3.2. Microarray Instruments
7.3.2.1. Microarray Scanners
7.3.2.2. Arrayers
7.4. Spectroscopy
7.4.1. Mass Spectroscopy
7.4.2. NMR Spectroscopy
7.4.3. CD Spectroscopy
7.5. Electrophoresis
7.5.1. Gel Electrophoresis
7.5.2. Capillary Electrophoresis
7.6. X-Ray Crystallography
7.7. Surface Plasmon Resonance
7.8. Protein Fractionation
7.9. Others
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Drug Discovery *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Clinical Diagnostics
8.4. Others
9. By Services and Software
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Services and Software
9.1.2. Market Attractiveness Index, By Services and Software
9.2. Bioinformatics Software and Services *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.2.3. Bioinformatics Services
9.2.4. Bioinformatics Tools
9.2.5. Bioinformatics Databases
9.3. Core Proteomics Services
9.3.1. Protein Identification Services
9.3.2. Protein Characterization Services
9.3.3. Quantitative Proteomics Services
9.3.4. Protein Purification Services
9.3.5. Protein Separation Services
9.3.6. Protein Sequencing Services
9.3.7. Custom Assay Services
9.4. Reagents
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals *
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Research Laboratories
10.4. Biopharmaceutical Companies
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Instrumentation Technology
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Services and Software
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Instrumentation Technology
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Services and Software
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. U.K.
11.3.7.3. France
11.3.7.4. Spain
11.3.7.5. Italy
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
12.4.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Instrumentation Technology
12.4.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Services and Software
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.5.1. Brazil
12.4.5.2. Argentina
12.4.5.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Instrumentation Technology
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Services and Software
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Instrumentation Technology
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Services and Software
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Thermo Fisher Scientific Inc. *
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Danaher
13.3. Agilent Technologies, Inc.
13.4. Bio-Rad Laboratories, Inc.
13.5. Bruker
13.6. Merck KGaA
13.7. Promega Corporation
13.8. Waters Corporation
13.9. PerkinElmer Inc.
13.10. MaxCyte
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us